Related by context. All words. (Click for frequent words.) 71 cystic fibrosis inflammation autoimmune 68 immuno inflammatory diseases 68 inflammation autoimmune diseases 68 syndrome overactive bladder 68 polyneuropathy HIV DSP 67 Vitrasert ® 65 Vitrasert R 65 HIV distal sensory 65 myocardial infarction hypersensitivity 65 myocardial infarction ventricular fibrillation 65 Pharma Merck Serono 65 sanofi aventis Bayer Schering 65 treat musculoskeletal metabolic 64 hypertension osteoarthritis 64 diabetes mellitus autoimmune disorders 64 neuromuscular spasm 64 postherpetic neuralgia PHN painful 64 BioMarin develops 64 R Saizen R 64 developing Bicifadine serotonin 64 milnacipran HCl 63 post herpetic 63 headache abdominal pain 63 alfimeprase direct 63 Acute Exacerbations 63 include Healive TM 63 allosteric modulator PAM 63 estrogen receptor beta agonist 63 erythematosus 63 Initiates Enrollment 63 weakness dizziness headache 63 infectious diseases autoimmune diseases 63 Boehringer Ingelheim MedImmune 63 epilepsy multiple sclerosis 63 Mg Uk 63 neutropenia thrombocytopenia 63 peripheral arterial occlusive disease 62 including thyroiditis RA 62 Mylan Receives Approval 62 atopic dermatitis neonatal 62 Begins Dosing 62 CHEAP ONLINE PHARMACY LOW 62 TRANSDUR ® 62 primary dysmenorrhea 62 sapropterin dihydrochloride 62 systemic lupus erythematosus psoriasis 62 FDA APPROVES 62 Luveris R Ovidrel R 62 Initiates Phase II 62 Initiates Clinical Trial 62 commercializes innovative biopharmaceuticals 62 vaginal candidiasis 62 Meets Primary Endpoint 61 neurology cardiovascular GIT 61 muscle cramps tiredness 61 attacks TIAs 61 Completes Patient Enrollment 61 Cytogen marketed 61 POSIDUR TM ELADUR TM 61 migraines neurorehabilitation 61 Treatment Shows Promise 61 Therapeutic Competitors Companies 61 bronchospasm dizziness headache 61 Ovitrelle R Serostim 61 hypercholesterolemia liver 61 diarrhea fatigue asthenia 61 Merck Serono Nycomed 61 asthma COPD Chronic 61 HPV cervical dysplasia 61 systemic autoimmune 61 palonosetron hydrochloride Injection Dacogen 61 Zorbtive TM 60 cardiovascular cerebrovascular 60 pralatrexate injection folate analogue 60 include ClindaReach TM 60 Merck OSI Pharmaceuticals 60 ergot derivatives 60 dyspnea dermatitis eczema 60 Phase 2b Clinical Trial 60 Acute Renal Failure 60 kidney urologic 60 Investigational Treatment 60 diabetes sciatica 60 Multiple Sclerosis Rheumatoid Arthritis 60 vitreoretinal disorders 60 Obstructive Pulmonary Disease 60 thrombotic disorders 60 lexidronam injection 60 JAK2 Inhibitor 60 hypersensitivity reactions eg anaphylaxis 60 diarrhea predominant irritable 60 Detrol Detrol LA 60 commercializing therapeutic 60 Alzheimer disease cognitive impairment 60 Cephalon GlaxoSmithKline Schering Plough 60 Vaccine Adjuvant 60 Novel Oral 60 IG HCR ;) CO 60 Gonal f R 60 constipation OIC 59 markets HP Acthar 59 Systemic lupus erythematosus SLE 59 liver cancers TTR 59 SHAREHOLDERS ARE STRONGLY ADVISED 59 toenail onychomycosis 59 management urology endocrinology 59 COMUNICADO DE 59 Therapeutic Competitors Report 59 sirtuin inhibitor program 59 Presents Positive 59 Complicated Skin 59 Wafer polifeprosan 59 Orthop Surg 59 inflammatory autoimmune diseases 59 essential thrombocythemia ET 59 platform HDL Mimetic 59 Physician Insights 59 sarcoma melanoma 59 autotransfusion systems 59 J Am Acad 59 Files IND 59 Kuvan TM sapropterin 59 Initiates Clinical Trials 59 dysphagia esophagitis 59 Agonist MABA program 59 Provectus Pharmaceuticals specializes 59 Submits NDA 59 Pneumocystis pneumonia PCP 59 Licenses Novel 59 Nasdaq PGNX 59 Receives Orphan Drug Designation 59 including acne photodamage 59 fibrosis oncology 59 rheumatoid arthritis viral infections 59 Peyronie disease Frozen Shoulder 59 Nasdaq MSON designs 59 Completes Enrollment 59 R metformin Concor 59 Mg Usa 59 liver cancers hypercholesterolemia 59 Circulation Chronic Digestive 59 EARLY SUNDAY 59 NYSE PFE Exelon Rivastigmine 59 fibrosis IPF 58 neuropathic pain metabolic diseases 58 Namenda Memantine HCl 58 R MSCRAMM 58 proprietary radiolabeled monoclonal 58 Drug Candidate 58 fungal infections malaria tuberculosis 58 cardiometabolic diseases Glucophage 58 candidates Azedra TM 58 INDICATED LOWER 58 oncolytic virus therapies 58 Patients Suffering 58 CRMD pharmaceutical 58 HA viscoelastic products 58 PULLBACK IN SHARES OF 58 multiple sclerosis psoriasis 58 Asthma COPD 58 REACHES INITIAL SUPPORT LEVEL 58 Nasdaq AEGR 58 Endocrinol 58 WeissComm Partners +#-#-#-# 58 www.ucb.com 58 WHILE THE COMPANY 58 Reveals Positive 58 DOWNGRADE ALERT WATCH FOR 58 Hematology Molecular Pathology 58 equine osteoarthritis marketed 58 BREAKS ABOVE 3 58 TRACON Pharmaceuticals 58 visit http:/www.ininc.us 58 FDA Clears 58 NYSE Amex AEN 58 Successfully Treats 58 endocrinology gastroenterology 58 Initiates Phase III 58 Disturbances Chronic Infections 58 hyperplasia BPH 58 acetonide FA 58 gastrointestinal disorders ATI 58 targeting Inflammatory Bowel 58 By Kathleen Doheny 58 HAIL AND DAMAGING WINDS 58 J Am Coll 58 Diovan Exforge Tekturna Zelnorm 58 MONSTERSTOX.COM Monsterstox.com 58 lead molecular radiotherapeutic 58 Maven Semantic 57 Earns Milestone Payment 57 Slows Progression 57 Genentech sanofi aventis 57 includes Dideco CarboMedics 57 BIOTECHNOLOGY SOURCE 57 epilepsy neuropathic pain 57 Receives Approvable Letter 57 Alvine Pharmaceuticals 57 Child Adolesc Psychiatry 57 Fibromyalgia Syndrome FMS 57 Bronchopulmonary Dysplasia 57 Femring ® 57 LONG WAIT FOR 57 Best Pract Res 57 Crit Rev 57 Transdermal Patch 57 Roche Boniva 57 Warner Chilcott Actonel 57 www.ucb group.com 57 GABLES MIAMI 57 THE HOMEFURNISHING RETAIL INDUSTRY 57 gastroenterology neurology 57 Reports Preclinical Data 57 J Shoulder Elbow 57 intraocular lenses IOLs phacoemulsification 57 PFIZER INC. 57 Marcus Gronholm BP 57 Presents Preclinical Data 57 Bristol Myers Squibb Celgene 57 lymphoma myeloma 57 DAY PATTERN FOR 57 gastroenterology respiratory 57 Oral Fingolimod 57 HAVE BEEN IN 57 somatropin Kuvan R 57 Cephalon GlaxoSmithKline 57 Bristol Myers Squibb sanofi 57 J Allergy Clin 57 VentiRx Pharmaceuticals 57 rheumatoid arthritis systemic lupus 57 WIDESPREAD SNOW 57 molecular imaging radiopharmaceutical 57 gastroenterology obstetrics gynecology 57 rheumatoid arthritis psoriasis 57 gastrointestinal mucositis 57 INDUSTRY LEADERS 57 REMINDER ORLive Presents 57 See WARNINGS 57 acne impetigo 57 'S SHARES CHANGING 57 HIGH GRADE BOND SALES 57 dyslipidemia hypertension diabetes 57 TO ASSET RATIO 57 hematological abnormalities 57 FOUND WITH 57 EARNINGS LOOK AHEAD 57 FDA Okays 57 respiratory gastrointestinal 57 rheumatoid arthritis Crohn disease 57 Phase 2a Clinical Trial 57 By DAN MORAN 56 Other ImmunoGen collaborative 56 TNF Blockers 56 FROM THE COMPANY 56 'S EFFORTS TO 56 Bearish Harami Pattern 56 Generalized Anxiety Disorder GAD 56 THE TREND CONTINUES LOWER 56 SMARTREND 'S OPTION SCANNER 56 Bearish Average Crossover 56 Reprod Biol 56 THE TREND CONTINUES DOWN 56 Drug Shows Promise 56 Parkinson disease monogenic diseases 56 Announces License Agreement 56 BULLISH MOVING AVERAGE CROSSOVER 56 DAX PJT bio 56 XIAFLEX ® 56 Limb Ischemia 56 Dengue hemorrhagic fever DHF 56 dermatological disorders 56 RAVENS DNP 56 Initiates Phase 2b 56 Submits Response 56 osteoarthritis osteoporosis 56 Tambocor 56 endocrine diseases 56 Gets FDA Clearance 56 Migranal 56 INDICATED HIGHER 56 Announces FDA Clearance 56 rheumatoid arthritis gout 56 Veronate R 56 PRN4 56 musculoskeletal diseases 56 Tramiprosate ALZHEMED TM 56 Drug Prevents 56 Announce License Agreement 56 products MKC# PP 56 WHERE PRESIDENT OBAMA 56 cardio cerebral vascular 56 CONTINUE THEIR 56 CONFERENCE CALLS SOURCE 56 Natural Hormone Replacement 56 SEXUALLY ASSAULTING 56 UPSIDE POTENTIAL 56 OTCBB NVLT biopharmaceutical 56 THE TREND CONTINUES HIGHER 56 HIV AIDS neuropathic pain 56 CTAP# 56 prescribe Trileptal 56 GRUMET Times Staff Writer 56 CALL VOLUME UP 56 Receives Milestone Payment 56 1hour #mins #.#secs M 56 FDA Approvals 56 BioSante Pharmaceuticals Announces 56 benign prostatic hypertrophy BPH 56 HAS RETURNED 56 STOCK ON 56 GI motility disorders 56 KM HR.WITH HIGHER GUSTS 56 Bullish Average Crossover 56 Vaccine Protects Against 56 LOUISMO 56 Patient Enrollment 56 autoimmune inflammatory 56 Novartis Novo Nordisk 56 Successfully Completes Tender Offer 56 ophthalmology dermatology 55 TO HELP THE 55 immunologic diseases 55 Solazed TM 55 Inc Therapeutic Competitors 55 WILL FEATURE 55 advanced compound INCB# 55 bladder ovarian 55 SCHOOL MENUS 55 Systemic Sclerosis 55 Eur Arch 55 Kendler Contributing Editor 55 Enlarged Prostate 55 BREAKS GROUND ON 55 WEEK HIGH RECENTLY ECLIPSED 55 subsidiaries InnerCool Therapies 55 equine osteoarthritis 55 Arch Otolaryngol Head 55 visit www.PAREXEL.com 55 为了 55 visit http:/www.PAREXEL.com 55 Patients Receiving 55 Phase IIb Clinical Trial 55 Receives Fast Track 55 HYVISC R 55 injectable bulking agent 55 Improves Outcomes 55 ORLive Presents 55 Announces Poster Presentations 55 Combination REOLYSIN R 55 FOR SHARES OF 55 PUT VOLUME UP 55 Liprotamase 55 SHARES SLIDING LOWER DOWN 55 THE TREND CONTINUES UP 55 rheumatoid arthritis psoriatic arthritis 55 Bearish Speculation 55 Options Trader Alert 55 STELARA TM 55 DOLLARS TO 55 Renal Impairment 55 By Dave Rosengrant 55 SHORT INTEREST 55 Skin Care Wei 55 Reminyl galantamine 55 aripiprazole Abilify 55 HE CAN BE 55 Ovidrel R Ovitrelle R 55 EPS ESTIMATES FOR 55 candidates Azedra 55 Amgen Bayer Schering 55 Frozen Shoulder syndrome 55 BREAKING ABOVE 55 Aztreonam Lysine 55 Commercialize Novel 55 IS CHARGED WITH 55 Sudhir Agrawal D.Phil 55 Patients Treated With 55 AUDIO PROVIDED BY 55 BOHANNAN 55 neurovascular diseases 55 GOES FROM 55 FDA Accepts 55 Initiates Clinical 55 Gets Bearish Confirmation 55 Vulvar 55 rheumatoid arthritis lupus 55 peptide peptide mimetic 55 SIX RO ROG 55 IS GOING BACK IN 55 surgery cardiology ophthalmology 55 rheumatoid arthritis thrombocytopenia 55 notes Nov #/NA 55 Lowers Risk 55 DETECTS UNUSUAL ACTIVITY IN 55 inflammatory autoimmune 55 By CHRIS WOODKA 55 Zemiva TM 55 COMPLETES ACQUISITION OF 55 #-MILLION DOLLARS [002] 55 MKC# MKC# PP 55 Nonalcoholic fatty liver 55 ACTIVATION REQUESTED SEVERE THUNDERSTORM 54 Annu Rev 54 Receives Orphan Drug 54 SET TO POSSIBLY PULLBACK 54 BUYERS ACCUMULATE SHARES OF 54 Successfully Completes Phase 54 INDUSTRY OFFERING INVESTORS 54 ATTR PN 54 NewsBite Downgrade Puts Pressure 54 Selective Electrochemical Tumor Ablation 54 Ception Therapeutics 54 Software Seapine Software 54 CONFERENCE CALLS EARNINGS SOURCE 54 Receive Milestone Payment 54 J Cataract Refract 54 respiratory allergy dermatological 54 Bullish Technical Alert 54 mlynch@nwherald.com 54 REVEALS NEW 54 & TRANSPORTATION INDUSTRY 54 AS PUT VOLUME 54 Epilepsy Drug 54 Free Full Text 54 CYTEC INDUSTRIES 54 Generalized Anxiety Disorder 54 Anacin pain relievers 54 Calls Purchased 54 purinergic receptors P#X# 54 Advanced Melanoma 54 Atopic Dermatitis 54 IV Busulfex 54 See CLINICAL PHARMACOLOGY 54 WILL BE REPORTED IN 54 cardiology nephrology 54 Skin Disorders 54 Bronchiectasis 54 LOCAL GOVERNMENT REPORTER 54 Services #:#-#,# Abstract 54 'S QUARTERLY RESULTS 54 FALLS BELOW 3 54 HIGHER ON #.#X ABOVE 54 Generic Versions 54 HAS RELATIVELY LOW UPSIDE 54 Curr Opin 54 Teva Provides Update 54 access graft VAG 54 including eniluracil ADH 54 SERVICES INDUSTRY 54 targeted radiotherapeutic 54 TRIDENT MICROSYSTEMS 54 menopause contraception 54 STEELERS OUT 54 REMAINS IN EFFECT UNTIL 54 Gastro intestinal 54 BY ADAM LISBERG 54 Adagen ® 54 HP Acthar Gel repository 54 NEW YORK YANKEES Recalled 54 Faisal Duguid 54 Specialty Compounding 54 EXTEND OUTWARD UP 54 #.# ENTERS NEW 54 inflammation metabolic disorders 54 AMEX REX 54 RELEASES ITS QUARTERLY NUMBERS 54 Attracting Bullish Investors 54 DepoCyt 54 Prodarsan R 54 Sleep Disturbances 54 HER2 Positive 54 BEARISH MOVING AVERAGE CROSSOVER 54 By MATT KATZ 54 LUNESTA ® 54 EnteroMedics proprietary neuroblocking technology 54 anti infective treatments 54 commercialize deforolimus 54 CROSSES PIVOT POINT RESISTANCE 54 Announces Licensing Agreement 54 Oral Calcitonin 54 Moving Average Crossover Alert 54 IN TERMS OF RELATIVE 54 IS HOPING TO 54 # AMC 54 BETHEL UNIV 54 Exploit collaboration 54 INTERACTIVE ENTERTAINMENT 54 模拟 54 Completes Tender Offer 54 'S BUY RECOMMENDATION 53 BREAKS THROUGH SUPPORT 53 oncology dermatology 53 COMPANY ASSUME ANY RESPONSIBILITY 53 EQUITAS NOMINEES PTY 53 label Lipofen R 53 Larne Holyhead 53 IN EFFECT THROUGH THIS 53 Taiho Pharmaceutical 53 OTC BB PVCT 53 COLTS OUT 53 #-# Full Text 53 SURVEY FINDS 53 Paris IPN Euronext 53 OTCBB HNAB 53 NEXT SUPPORT LEVEL FOR 53 Painful Bladder Syndrome Interstitial 53 Kinase Inhibitor 53 BY TAMER EL GHOBASHY 53 HARD DRIVES #GB 53 Hematologic Oncology 53 Welcomes Analyst Initiation 53 REUNITE FOR 53 Puts Purchased 53 cardiovascular metabolic 53 SPECULATE ON HIGHER PRICES 53 GATTEX TM 53 XmAb ® 53 Interesting Options Volume 53 Therapeutic Competitors 53 By DIANE CARROLL 53 Traders Hedging Bets 53 IS COMPLETE 53 DAY TRADING RANGE 53 STRANGE de 53 Electrophysiology Cardiovascular Surgery 53 ON SHARES OF 53 Eur J 53 Author Affiliations Division 53 EZchip Semiconductor Nasdaq EZCH 53 Soft Tissue Sarcoma 53 nephrology neurology 53 Preclinical Data 53 Therapeutic Competitors companiesandmarkets.com adEgemonye 53 CROSSES PIVOT POINT SUPPORT 53 diseases fat malabsorption 53 Basal Cell 53 BY ALFONSO CHARDY 53 Solazed ™ 53 Warfarin Coumadin 53 ophthalmology oncology 53 neurology immunology 53 Anti Inflammatory 53 Prophylactic Treatment 53 Reconstruction Trauma 53 Immunotherapeutic 53 BellwetherReport.com Analyst Report 53 Successfully Completes Acquisition 53 aesthetic dermatological conditions 53 Arno Therapeutics 53 By CATHERINE MACRAE 53 Pharmacyclics Announces 53 Cuttermill Road Great Neck 53 cardiovascular neuroscience 53 drugs FUSILEV 53 serotonergic drugs 53 Cardiovascular Prosthetic Devices 53 PRESSURE IN SHARES OF 53 ANNOUNCES ACQUISITION OF 53 SHARES COULD POTENTIALLY PULLBACK 53 dermatology urology gynecology orthopedics 53 orthopedics oncology 53 Germany FSE SCH 53 dermatology oncology neurology 53 Detects Unusual Activity 53 LAWYER SAYS 53 Secondary Hyperparathyroidism 53 THE PARTICIPANTS PROXY SOLICITOR 53 Posts Large Volume 53 visit http:/www.diabetes.org 53 EBITDA RATIO 53 APPEARANCE IN 53 ESTIMATE BELIEVE CONTINUE 53 Demonstrates Sustained 53 About Positron Positron 53 gastroenterology orthopedics 53 TRAIL receptor antibodies 53 dermatology therapies 53 myelofibrosis polycythemia vera 53 Shareholders Approve Merger Agreement 53 HCV Protease Inhibitor 53 -Accused rapist 53 Anthracycline 53 oncology infectious diseases 53 Unveils Upgraded 53 FALLS THRU 53 #/#/# COMPANY AMT [001] 53 EXPECTED FOR WEEK 53 testosterone buccal system 53 Second Quarter Earnings Preview 53 #:#-#,# CrossRef Medline [001] 53 customizable drug eluting 53 urethral bulking agent 53 IND Filing 53 CORP AMT 53 Canaccord Genuity Maintains Hold 53 Schaeffer Sentiment Snapshot 53 Q3 Loss Widens 53 incontinence erectile dysfunction 53 J Clin 53 Cellegy Pharmaceuticals 52 psychiatry neurology 52 Receives SFDA Approval 52 TO APPROACH SUPPORT 52 dermatology gastroenterology 52 Posts Large 52 By PEGGY O'HARE 52 ANN INTERN MED 52 Progressive Multifocal Leukoencephalopathy 52 Adams MD Nastran 52 Thromboembolic 52 NICE Recommends 52 STEELERS DNP 52 Files Shelf Registration Statement 52 BREAKS THROUGH RESISTANCE AT 52 www.sorin.com 52 Crosses Above 52 development DSC# novel 52 Downgrade Alert Watch 52 Signal Transducers 52 novel immunotherapies 52 Dermatol 52 endoluminal stent graft 52 Noven Therapeutics Noven 52 Hervé Hoppenot President 52 Benign Prostatic Hyperplasia 52 metastatic gastric 52 CAN YOU GO 52 ANNOUNCES THE 52 Bullish Speculation 52 Overactive Bladder 52 Ridaforolimus 52 APPROACHES NEW DOWNSIDE TARGET 52 neurology orthopedics 52 HuCAL PLATINUM R 52 By MARK BURGESS 52 inVentiv Patient Outcomes 52 AFREZZA TM 52 endocrine abnormalities 52 Vertebral Fractures 52 dense scraggly underbrush 52 Crohn disease CD 52 Present Preclinical Data 52 Soludia 52 Inflammatory Diseases 52 PROSTASCINT R 52 Squamous 52 Visit www.BASInc.com 52 Put Volume Surges 52 Reuters code SORN.MI 52 Vascular Disrupting Agent 52 Placed LHP 52 TO SERVE AS 52 Canaccord Genuity Reiterates Buy 52 TO APPROACH RESISTANCE AT 52 co name = 52 M.D. Ph.D. 52 SALES COMPANY Amt Mat 52 Prolongs Survival 52 Specialized Therapeutics 52 Verstovsek 52 #:#-#,# CrossRef Medline [002] 52 MANAGEMENT CHANGES SOURCE 52 Avonex interferon beta 1a 52 WOMEN 'S SEEDED LOSERS 52 EFFECT FROM 52 Vascular Grafts 52 Jacque Jones Ronny Cedeno 52 Topical Solution 52 By Gabriel Rizk 52 HEDGE POSITION 52 MD MHSc 52 AVI BioPharma Announces 52 BY MICHAEL O'KEEFFE 52 treating cancerous tumors 52 #:#-#,# [001] 52 By KATHY ROUTLIFFE 52 Dupuytren Disease 52 information visit www.valcent.net 52 INDIANAPOLIS HAS ISSUED 52 Regenerative Cells 52 Immune Mediated 52 Jetta Jetta SportWagen Eos 52 Arterial Disease 52 PRODUCT SOURCE 52 #/#/# COMPANY AMT [002] 52 ANNOUNCES PARTNERSHIP WITH 52 gastric pancreatic 52 Neutrolin ® 52 Prostacyclin 52 By JENNY DIAL 52 NEUPOGEN R 51 Systemic lupus erythematosus 51 Injection PERLANE ® 51 MARCY SUGAR anniesmailbox@comcast.net 51 ACACIA RESEARCH 51 ON SCREEN LOGO MUST 51 Alastair Cook Essex 51 Inflammatory Disease 51 SOMEONE WOULD 51 Lowest Operating Margin 51 Female Stress Urinary 51 SIGNIFICANT SNOW 51 orthopedics urology 51 surgical instruments electrosurgery 51 Investor Relations +#-#-#-# x# 51 Completes Merger With 51 pediatrics neurology 51 website www.arinet.com 51 Investigational Compound 51 StromaCel Inc. 51 pediatric Crohn disease 51 Oral Mucositis 51 STIFEL FINANCIAL 51 -grassless 51 Inc. Subsidiary Awarded 51 PROFILE CO 51 Novel Therapeutic 51 Anti Tumor 51 WHILE WORKING 51 Benign prostatic hyperplasia BPH 51 ifosfamide standard 51 neurology psychiatry 51 Innovive Pharmaceuticals 51 NASDAQ PPDI 51 Infect Control 51 neuropathic pain nerve 51 Expanded Indication 51 Guides FY# Quick Facts 51 THE UTILITIES SECTOR 51 MAY SEEK 51 Atelvia 51 EFFECT FOR 51 Fourth Quarter Earnings Preview 51 diagnostic molecular imaging 51 dermatology urology 51 TO NEGATIVE 51 Geriatr 51 Evoltra ® 51 UPTREND CALL 51 Activated 1B 51 Chronic Heart Failure 51 Alexa Davalos Defiance 51 Psoriasis Drug 51 Earnings Postmortem 51 Announce Expiration 51 tPA antithrombotics anticoagulation therapy 51 Voluntarily Withdraws 51 Adjuvant Chemotherapy 51 Ceflatonin R 51 Lymphocytic 51 oncology gastroenterology 51 By JEAN TARBETT 51 Fibromyalgia Pain 51 Activated LHP 51 #/#/# COMPANY AMT [003] 51 Ondansetron Orally Disintegrating Tablets 51 anti infectives cardiovascular 51 FOR THE FOLLOWING 51 By DAN MARGOLIES 51 urology cardiology 51 Carcinomas 51 THE COMPUTER HARDWARE 51 Reiterates FY# Outlook 51 ATHEROS COMMUNICATIONS 51 Cardiovasc 51 COMP COMP COMP COMP 51 Clinical Trial Results 51 Guides Inline 51 MARKETING AGREEMENTS PRODUCT SOURCE 51 AMT MAT DEBT RTGS 51 Technical Uptrend Reversal 51 neurology oncology 51 rheumatoid arthritis ankylosing spondylitis 51 http:/www.unigene.com 51 neurology dermatology 51 #:#-# [024] 51 Subtypes 51 RELATIVE PERFORMANCE 50 Bungie Studios Mass Effect 50 SAN FRANCISCO GIANTS Optioned 50 Posts Large Volume Increase 50 Hargreaves Bayern Munich 50 Recap HOU 50 Martin Nicklasson CEO 50 cardiovascular gastrointestinal 50 BOND SALES COMPANY AMT 50 BB SO Avg 50 neurology gastroenterology 50 Crosses Pivot Point 50 Novel Treatments 50 Proven Effective 50 PharmaPros Corporation 50 urology gastroenterology 50 Contributing Writer myOptumHealth 50 Syndax Pharmaceuticals Inc. 50 THE PUBLISHING INDUSTRY 50 Advanced Prostate Cancer 50 arthroscopy powered 50 FLOOD WATCH REMAINS IN 50 TRADING RANGE 50 Debt Rtgs Mgrs Priced 50 herpetic keratitis 50 High Recently Eclipsed 50 Nephrology Neurology 50 pacemakers implantable cardioverter defibrillatorsHELB 50 BY JOE MAHONEY 50 ProAct Traders ™ 50 NA BAS 50 Arthritis Musculoskeletal 50 Aloxi ® 50 EAGLES DNP 50 Nancy Wysenski 50 By RICK ALM 50 By KEVIN KADUK 50 Hyderabad Indore Jaipur 50 SALES COMPANY AMT MAT 50 Lita Annenberg Hazen 50 WINDOWS AND 50 Osteoporosis Treatment 50 Sanofi Aventis Schering Plough 50 NEXT RESISTANCE LEVEL FOR 50 MRI Patient Monitoring 50 Activated 3B 50 Anti Angiogenesis 50 External Beam 50 Endures Analyst Downgrade 50 -#.# ohne Zeitangabe 50 SERIES PREVIEW 50 -ground truthing 50 Muscle Wasting 50 UTSTARCOM 50 ADVERTISING MARKETING 50 neurosciences orthopedics 50 BOND SALES COMPANY Amt 50 NEW YORK METS Optioned 50 YIELD BOND SALES COMPANY 50 RDavis 50 Therapeutic Antibody 50 Allergic Rhinitis 50 BAS CITI JPM 50 Monoclonal Antibody 50 Inflammatory Arthritis 50 Barnsley Doncaster Rovers 50 Enteral Feed Devices 50 ENTERS NEW 50 Demyelinating 50 Finerman Firm 50 Product Segment Hip Prosthesis 50 statins Diabetology Asthma 50 Alessandro Riva 50 #:#-#,# Medline 50 Winning Streak Continues 50 Settle Patent Dispute 50 Preterm Labor 50 Sarah Brumfeld 50 Post Earnings Checkup 50 Bone Fractures 50 Linda Orehovec 50 Renal Cancer 50 SCastro Chicago 50 Boosts Estimates 50 PGL# 50 Enters Oversold Territory 50 Hip Fractures 50 RNAi Therapeutics 49 PAYOUT FOR 49 Bearish MACD 49 neurosurgery orthopedics 49 Faropenem 49 simplex virus 49 Marillion Pharmaceuticals 49 MICROCHIP TECHNOLOGY 49 BUSINESS NOTES 49 vascular disorders 49 KEYWORD MASSACHUSETTS INDUSTRY KEYWORD 49 #:#-#,# CrossRef 49 Psychol 49 t2cure GmbH 49 Recalled INF OF 49 Anthony Becht TE 49 Injection PERLANE R 49 Therapeutix 49 SALES EXPECTED FOR 49 Onalta TM 49 MassGeneral Institute 49 orthopedics gynecology 49 Shareholders Approve Merger 49 pharmaceuticals nutritionals 49 Alert Trend Down 49 Minimally Invasive Procedure 49 Attu islands 49 Minitran 49 KEYWORD SOFTWARE 49 J Cardiovasc 49 TAKES FLIGHT 49 Investor Relations Herman Betten 49 OF Eli Marrero 49 Clinical Transfusion 49 Barclays Maintains 49 s crizotinib ZAH 49 Hepatitis C Virus HCV 49 MA Pervasip Corp. 49 Embolic Protection 49 3 yr frn 49 cardiopulmonary bypass extracorporeal circulation 49 yr Ba2/BB + 49 #/#-# KEYWORD CALIFORNIA INDUSTRY 49 DEBT RTGS MGRS PRICED 49 Announce Definitive Agreement 49 Squamous cell 49 Respiratory Disorders 49 Maintains Buy Rating 49 Viktor Yanukovych Latvian 49 VBLOC ™ 49 % # BTO 49 Autoimmune Disease 49 RHP Kam Mickolio 49 Cerebral Somatic Oximeter 49 vascular urology oncology 49 Clinical Therapies Endoscopy 49 Tissue Repair Company 49 Bearish Pressure Building 49 Immunosuppressive 49 Alza Corporation 49 oncology immunology 49 LBs Boss 49 -prefixing 49 Completes Debt Refinancing 49 Dividend Yield Outperforms 49 Develops Novel 49 HARDWARE SOFTWARE 49 -David Gibbon Gaming 49 Actinic Keratosis 49 Crossover Alert 49 Antifungal 49 Recap TOR 49 Diabetes Hypertension 49 Genes Identified 49 KEPT THE 49 By TOM FOWLER 49 COMPANY Amt Mat Debt 49 ophthalmology orthopedics 49 Cetrorelix 49 OFFICE AND 49 Recap NYY 49 TAKES AIM 49 THIRD TEAM 49 -Sukhvinder 49 gynecology pediatrics 49 Apricus Biosciences 49 Has Torn ACL 49 gynecology orthopedics 49 Autoimmune Diseases 49 Global Injectables 49 Stock Downgraded 49 photo ablating 49 Reduces Mortality 49 Stifel Nicolaus downgrades 49 Volume Increase Hits 49 ExxonMobil Fluor 49 OUTFIELDERS 49 China BAK undertakes 49 #ka Year 48 includes ExploreLearning IntelliTools 48 CONSUMER HOUSEHOLD 48 Stock Upgraded 48 Valvular 48 Riders Royal Challengers 48 Berg BioMarin Pharmaceutical 48 MARINERS PROBABLE STARTER 48 Acute Treatment 48 RNAi Therapeutic 48 miconazole MBT 48 Preclinical Models 48 gastrointestinal malignancies 48 Cardiac Stem Cell 48 dermatologic disorders 48 Anticonvulsant 48 Mobile NBC 2Go 48 Kenya Mozambique Namibia 48 LEADERS Offense 48 Fibrin Patch 48 hypervascular tumors 48 hematological disorders 48 #:#-#,# [002] 48 IG IGS ;) CO 48 Stress Urinary Incontinence 48 Recap DET 48 psychiatry pediatrics 48 Lindsay Tarpley Kalamazoo Mich. 48 MEEGAN M. REID KITSAP 48 Menopausal Symptoms 48 Novel Vaccine 48 Oncology Primary Care 48 #:#-# [031] 48 Myelodysplastic Syndromes 48 Trend Continues Down 48 Cell Transplants 48 Insulin Delivery